ENO2 and neuroendocrine neoplasm: Its levels are significantly elevated compared to healthy subjects; however, specificity and sensitivity are too low to be used in screening.39,91 According to the recommendations of expert groups for the use of markers in lung cancer, gamma-enolase is recommended as an auxiliary marker in SCLC for differential diagnosis when biopsy is not possible and when other neuroendocrine tumours are excluded.